Vigilare Wealth Management Horizon Therapeutics Public LTD CO Transaction History

Vigilare Wealth Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$58.92 - $84.67 $1,178 - $1,693	-20 Reduced 0.44%	4,513 $279,000
Q2 2022 Jul 11, 2022	SELL	$79.4 - $116.36 $205,407 - $301,023	-2,587 Reduced 36.33%	4,533 $362,000
Q1 2022 Apr 06, 2022	SELL	$86.42 - $109.81 $190,124 - $241,582	-2,200 Reduced 23.61%	7,120 $749,000
Q4 2021 Jan 07, 2022	SELL	$98.56 - $119.91 $14,784 - $17,986	-150 Reduced 1.58%	9,320 $1 Million
Q3 2021 Oct 19, 2021	SELL	$91.91 - $110.37 $3,676 - $4,414	-40 Reduced 0.42%	9,470 $1.04 Million
Q2 2021 Jul 16, 2021	SELL	$86.24 - $95.92 $60,368 - $67,144	-700 Reduced 6.86%	9,510 $891,000
Q1 2021 Apr 29, 2021	SELL	$71.83 - $95.48 $55,668 - $73,997	-775 Reduced 7.06%	10,210 $940,000
Q4 2020 Jan 14, 2021	BUY	$67.0 - $84.39 $252,724 - $318,319	3,772 Added 52.29%	10,985 $804,000
Q3 2020 Oct 15, 2020	BUY	$55.23 - $79.93 $16,569 - $23,979	300 Added 4.34%	7,213 $560,000
Q2 2020 Jul 20, 2020	SELL	$30.2 - $56.98 $56,927 - $107,407	-1,885 Reduced 21.43%	6,913 $384,000
Q1 2020 May 04, 2020	BUY	$24.87 - $38.56 $218,806 - $339,250	8,798 New	8,798 $261,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.